Morgan Stanley’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
462,606
+153,030
| +49% | +$349K | ﹤0.01% | 5062 |
|
|
2025
Q1 | $480K | Sell |
309,576
-243,558
| -44% | -$378K | ﹤0.01% | 5344 |
|
|
2024
Q4 | $1.3M | Sell |
553,134
-1,264,821
| -70% | -$2.97M | ﹤0.01% | 4951 |
|
|
2024
Q3 | $6.6M | Sell |
1,817,955
-1,086,888
| -37% | -$3.95M | ﹤0.01% | 3743 |
|
|
2024
Q2 | $10.1M | Buy |
2,904,843
+2,214,370
| +321% | +$7.71M | ﹤0.01% | 3316 |
|
|
2024
Q1 | $4.41M | Buy |
690,473
+527,735
| +324% | +$3.37M | ﹤0.01% | 4014 |
|
|
2023
Q4 | $1.05M | Buy |
162,738
+10,796
| +7% | +$69.5K | ﹤0.01% | 5267 |
|
|
2023
Q3 | $354K | Sell |
151,942
-8,372
| -5% | -$19.5K | ﹤0.01% | 5319 |
|
|
2023
Q2 | $382K | Buy |
160,314
+103,917
| +184% | +$247K | ﹤0.01% | 5352 |
|
|
2023
Q1 | $104K | Sell |
56,397
-38,865
| -41% | -$71.5K | ﹤0.01% | 5987 |
|
|
2022
Q4 | $181K | Buy |
95,262
+51,312
| +117% | +$97.5K | ﹤0.01% | 5706 |
|
|
2022
Q3 | $94K | Sell |
43,950
-24,433
| -36% | -$52.3K | ﹤0.01% | 6109 |
|
|
2022
Q2 | $194K | Sell |
68,383
-106,876
| -61% | -$303K | ﹤0.01% | 5918 |
|
|
2022
Q1 | $731K | Buy |
175,259
+19,319
| +12% | +$80.6K | ﹤0.01% | 5182 |
|
|
2021
Q4 | $809K | Sell |
155,940
-37,105
| -19% | -$192K | ﹤0.01% | 5233 |
|
|
2021
Q3 | $1.26M | Sell |
193,045
-85,219
| -31% | -$558K | ﹤0.01% | 4892 |
|
|
2021
Q2 | $1.85M | Buy |
278,264
+137,038
| +97% | +$910K | ﹤0.01% | 4692 |
|
|
2021
Q1 | $810K | Buy |
141,226
+12,017
| +9% | +$68.9K | ﹤0.01% | 4861 |
|
|
2020
Q4 | $1.16M | Buy |
129,209
+93,519
| +262% | +$836K | ﹤0.01% | 4581 |
|
|
2020
Q3 | $415K | Sell |
35,690
-54,888
| -61% | -$638K | ﹤0.01% | 4728 |
|
|
2020
Q2 | $1.45M | Buy |
+90,578
| New | +$1.45M | ﹤0.01% | 3878 |
|
|
2019
Q2 | – | Sell |
-27
| Closed | -$1K | – | 6636 |
|
|
2019
Q1 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 6498 |
|